Comprehensive Review of Preschool Age Anemia in the Pacific Island Jurisdictions

Tiffany F Lin1, James N Huang1, Haley L Cash1

  • 1UCSF Benioff Children's Hospital, San Francisco, CA (TFL, JNH).

Insights

Anemia is a significant health issue for children in Oceania, with prevalence varying widely across Pacific Islands. This review highlights data gaps and calls for standardized reporting to improve public health interventions.

Area of Science:

  • Public Health
  • Pediatrics
  • Nutritional Science

Background:

  • Anemia is a critical indicator of poor nutrition and health, disproportionately affecting children.
  • The Oceania region faces significant public health challenges related to childhood anemia.
  • Existing data on anemia prevalence in Pacific Island children is fragmented and lacks standardization.

Purpose of the Study:

  • To comprehensively review and summarize the available literature on anemia prevalence in young children across the Oceania region.
  • To establish a baseline for understanding anemia's scope in Pacific Island Jurisdictions.
  • To identify data limitations and inform future public health strategies.

Main Methods:

  • Systematic review of published literature on anemia prevalence in young children in Oceania.
  • Analysis of reported anemia prevalence, diagnostic criteria, data reporting dates, and sample types.
  • Inclusion of data from eighteen Pacific Island Jurisdictions, with regression analysis for data-scarce areas.

Main Results:

  • Anemia prevalence estimates were available for eighteen Pacific Island Jurisdictions.
  • Evaluated data from fifteen sources showed prevalence ranging from 12.3% to over 70%.
  • Significant limitations include a lack of representative primary data and non-standardized reporting criteria across jurisdictions.

Conclusions:

  • The review establishes a crucial baseline for anemia prevalence in Pacific Island children.
  • Identified data gaps necessitate further investigation with standardized methodologies.
  • Findings will aid in evaluating and improving public health interventions for anemia detection and treatment in the region.

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.4K
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
6.2K
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
6.2K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
337
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
9.9K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
4.0K